Sex modifies the APOE-related risk of developing Alzheimer disease
Altmann A, Tian L, Henderson VW, Greicius MD, Alzheimer's Disease Neuroimaging Initiative Investigators.. Annals of neurology, 2014-04-14
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Objective The APOE4 allele is the strongest genetic risk factor for sporadic Alzheimer disease (AD). Case-control studies suggest the APOE4 link to AD is stronger in women. We examined the APOE4-by-sex interaction in conversion risk (from healthy aging to mild cognitive impairment (MCI)/AD or from MCI to AD) and cerebrospinal fluid (CSF) biomarker levels. Methods Cox proportional hazards analysis was used to compute hazard ratios (HRs) for an APOE-by-sex interaction on conversion in controls (n = 5,496) and MCI patients (n = 2,588). The interaction was also tested in CSF biomarker levels of 980 subjects from the Alzheimer's Disease Neuroimaging Initiative. Results Among controls, male and female carriers were more likely to convert to MCI/AD, but the effect was stronger in women (HR = 1.81 for women; HR = 1.27 for men; interaction: p = 0.011). The interaction remained significant in a predefined subanalysis restricted to APOE3/3 and APOE3/4 genotypes. Among MCI patients, both male and female APOE4 carriers were more likely to convert to AD (HR = 2.16 for women; HR = 1.64 for men); the interaction was not significant (p = 0.14). In the subanalysis restricted to APOE3/3 and APOE3/4 genotypes, the interaction was significant (p = 0.02; HR = 2.17 for women; HR = 1.51 for men). The APOE4-by-sex interaction on biomarker levels was significant for MCI patients for total tau and the tau-to-Aβ ratio (p = 0.009 and p = 0.02, respectively; more AD-like in women). Interpretation APOE4 confers greater AD risk in women. Biomarker results suggest that increased APOE-related risk in women may be associated with tau pathology. These findings have important clinical implications and suggest novel research approaches into AD pathogenesis.
What this study adds
Evidence grade: Moderate
This is a case-control study of 5,496 participants. In 5,496 healthy older adults, carriers of the APOE4 gene variant were more likely to develop mild cognitive impairment or Alzheimer's, and the increase was larger in women than in men (hazard ratio 1.81 vs 1.27). Reported effect size: HR = 1.81; HR = 1.27; HR = 2.16.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Altmann, A., Tian, L., Henderson, V. W., Greicius, M. D., & Alzheimer's Disease Neuroimaging Initiative Investigators. (2014). Sex modifies the APOE-related risk of developing Alzheimer disease. Annals of neurology. https://doi.org/10.1002/ana.24135
Vancouver
Altmann A, Tian L, Henderson VW, Greicius MD, Alzheimer's Disease Neuroimaging Initiative Investigators. Sex modifies the APOE-related risk of developing Alzheimer disease. Annals of neurology. 2014. doi:10.1002/ana.24135. PMID: 24623176.
BibTeX
@article{altmann2014-24623176,
author = {Altmann, A. and Tian, L. and Henderson, V. W. and Greicius, M. D. and {Alzheimer's Disease Neuroimaging Initiative Investigators}},
title = {{Sex modifies the APOE-related risk of developing Alzheimer disease}},
journal = {Annals of neurology},
year = {2014},
doi = {10.1002/ana.24135},
pmid = {24623176},
url = {https://doi.org/10.1002/ana.24135}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Results Among controls, male and female carriers were more likely to convert to MCI/AD, but the effect was stronger in women (HR = 1.81 for women; HR = 1.27 for men; interaction: p = 0.011).
- The interaction remained significant in a predefined subanalysis restricted to APOE3/3 and APOE3/4 genotypes.
- Among MCI patients, both male and female APOE4 carriers were more likely to convert to AD (HR = 2.16 for women; HR = 1.64 for men); the interaction was not significant (p = 0.14).
- In the subanalysis restricted to APOE3/3 and APOE3/4 genotypes, the interaction was significant (p = 0.02; HR = 2.17 for women; HR = 1.51 for men).
- The APOE4-by-sex interaction on biomarker levels was significant for MCI patients for total tau and the tau-to-Aβ ratio (p = 0.009 and p = 0.02, respectively; more AD-like in women).
Why it matters
In 5,496 healthy older adults, carriers of the APOE4 gene variant were more likely to develop mild cognitive impairment or Alzheimer's, and the increase was larger in women than in men (hazard ratio 1.81 vs 1.27). Among 2,588 people who already had MCI, APOE4 raised the risk of progressing to Alzheimer's in both sexes (2.16 vs 1.64), but the sex difference was not statistically significant unless the analysis was limited to people with the APOE3/3 or 3/4 genotypes. In 980 ADNI participants, the APOE4 effect on spinal-fluid tau was more Alzheimer's-like in women with MCI, which the authors say "may be associated" with women's higher risk; this is an association, and the study tested no treatment.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Study designcase-control study
- Participants5,496
- Effect sizeHR = 1.81; HR = 1.27; HR = 2.16
- Evidence strengthModerate
How this study scored 74/100
Published in a leading specialty journal, and it is a case-control study. Scored zero for randomized / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 71 of the 96 points we could judge it on, which is 74 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Annals of neurology) |
| Journal's citation record | 3 / 4 | Annals of Neurology: journal h-index 437 (OpenAlex, 2026-10-29) |
| Study design | 6 / 12 | A case-control study |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2014 — within 20 year(s) of the newest study here |
| Sample size | 3 / 4 | 5,496 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 891 times (OpenAlex, 2026-10-10) |
| Citations per year | 5 / 5 | 63.6 citations a year over 14 year(s) since 2014 |
| Impact for its field and year | 5 / 6 | Cited 28.2× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 4 / 6 | Cited by 61 other studies in this library |
| Still being cited | 4 / 4 | Cited 298 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | 3 / 3 | Stanford University: institution h-index 2,684 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 24623176) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 71 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 71 of the 96 points we could judge it on is 74 out of 100. |
| Total | 74 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — PubMed Central lists this copy as free to read: the link above (checked 10 Oct 2026).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
61 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Genetics from nearby years
Also tagged “precursor”
1,337 studies in the library carry the topic tag “precursor”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,337 tagged studies.